medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2014, Número 4

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2014; 61 (4)


Proteínas de membrana externa de Serratia marcescens

Cervantes-García E, García-González R, Salazar-Schettino PM

Idioma: Español
Referencias bibliográficas: 29
Paginas: 224-228
Archivo PDF: 469.58 Kb.


RESUMEN

Serratia marcescens es un bacilo Gram negativo perteneciente a la familia Enterobacteriaceae, considerado un patógeno oportunista en pacientes inmunosuprimidos. Es causa importante de infecciones de vías urinarias, de neumonías, septicemias, meningitis, bacteriemias, endocarditis, peritonitis y osteomielitis, así como productora de brotes intrahospitalarios. En las últimas décadas, se ha incrementado la frecuencia en brotes en unidades de terapia intensiva por este microorganismo. La mayoría de los estudios sobre esta bacteria se han enfocado en su caracterización fenotípica. Sin embargo, los antígenos de la membrana externa de S. marcescens han sido poco caracterizados, así como su relación con la patogenicidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Grimont & Grimont. The genus Serratia. J Gen Microbiol. 1977; 72: 215-248.

  2. Grimont PA, Grimont F. Biotyping of Serratia marcescens and its use in epidemiological studies. J Clin Microbiol. 1978; 8: 73-78.

  3. Hejazi A, Folkiner FR. Serratia marcescens. J Med Microbiol. 1997; 46: 903-912.

  4. Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev. 2011; 24: 755-791.

  5. Berthelot P, Grattard F, Amerger C et al. Investigation of a nosocomial outbreak due to Serratia marcescens in a maternity hospital. Infect Control Hosp Epidemiol. 1999; 20: 233.

  6. Fleisher F, Zimmerman-Baer U, Zbinden R et al. Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis. 2002; 34: 767.

  7. Haddy RI, Mann BL, Nadkami DD, Cruz RF, Elshoff DJ, Buendia FC et al. Nosocomial Serratia marcescens infections associated with extrinsic contamination of a liquid nonmedicated soap. Infect Control Hosp Epidemiol. 2000; 21 (3): 196-199.

  8. Yu WL, Lin CW, Wang DY. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates. J Microbiol Inmunol Infect. 1998; 31 (3): 171-179.

  9. Hejazi A, Falkiner FR. Serratia marcescens. J Med Microbiol. 1997; 46: 903-912.

  10. Mahlen SD. Serratia infections: from military experiments to current practice. 2011; 24: 755-791.

  11. Schnaitman C. Solubilization of the cytoplasmic membrane of Escherichia coli by TritonX-100. J Bacteriol. 1971; 108: 545-552.

  12. Filip C, Fletcher J. Solubilization of cytoplasmic membrane of Escherichia coli by ionic detergent sodium laurel sarcosinate (Sarkosyl). J Bacteriol. 1993; 115: 717-722.

  13. Laemmli UK. Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature. 1970; 227: 680-685.

  14. Uemura J, Mizushima S. Isolation of outer membrane proteins of Escherichia coli and their characterization of polyacrilamide gel. Biochimica Biophysica Acte. 1975; 12: 368-372.

  15. Lowry OH, Rosebrough NJ, Farr AL. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265-275.

  16. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of protein from polyacrilamylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979; 76: 43-50.

  17. Challacombe S. Application of ELISA to microbiology. ELISA and other solid phase immunoassays. New York: John Wiley & Sons; 1988: pp. 319-355.

  18. Miura T, Mizushima Y. Separation and properties of outed membranae cytoplasmic membranes in Escherichia coli. Biochemica Biophys Acta. 1969; 193: 268-272.

  19. Bragg P, Hot C. Organization of protein in the native and reformed outer membrane of Escherichia coli. Biochem Biophys Acta. 1972; 274: 478-488.

  20. Lutenberg B, Meijers J, Joeck P, Alphen L. Electrophoretic resolution of major outer membrane protein of Escherichia coli K12 into four bands. FEBS Lett. 1975; 58: 254-258.

  21. Osborn MJ. Proteins of outer membrane Gram negative bacteria. Ann Rev Microbiol. 1980; 26: 369-378.

  22. Buchanan TM, Arko RJ. Immunity to gonococal infections induced by vaccination with isolated outer membrane of Neisseria gonorrhoea in Guinea pigs. J Infect Dis. 1977; 135: 879-887.

  23. Braun V, Rhen K. Chemical characterization spatial distribution and function of lipoproteinin membrane structure of Escherichia coli. Eur J Biochem. 1969; 10: 426-432.

  24. Puig M, Fusté C, Viñas M. Outer membrana proteins from Serratia marcescens. Can j Microbiol. 1993; 39: 108-111.

  25. Malouin F, Campbell GD, Halpenny M, Becker GW, Parr TR. Outer membrane porins characteristics of Serratia marcescens growth in vitro and in rat intraperitoneal diffusion chambers. Infection and Immunity. 1990; 58: 1247-1253.

  26. Hutsul J, Worobec E. Molecular characterization of a 40 kDa OmpC-like porin from Serratia marcescens porin protein. Can J Microbiol. 1994; 140: 379-387.

  27. Schonherr R, Higles M, Broer S, Bens R, Braun V. Interaction of Serratia marcescens hemolysin (ShlA) with artificial and erythrocyte membranes. Eur J Biochem. 1994; 223: 655-663.

  28. Ruan Y, Braun V. Hemolysin as a marker of Serratia marcescens. Arch Microbiol. 1990; 154: 221-225.

  29. Poole K, Schiebel E, Brau V. Molecular characterization of the hemolysin determinant of Serratia marcescens. J Bacteriol. 1988; 170: 3177-3188.




2020     |     www.medigraphic.com